Genematrix Inc. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genematrix Inc. with three other
companies in this sector in South Korea:
Cancer Rop Co Ltd
sales of 5.10 billion Korean Won [US$4.81 million]
GL Pharm Tech Corp
(4.64 billion Korean Won [US$4.37 million]
(5.29 billion Korean Won [US$4.99 million]
Genematrix Inc. reported sales of 5.08 billion Korean Won (US$4.79 million)
December of 2016.
decrease of 4.4%
versus 2015, when the company's sales were 5.32 billion Korean Won.